• UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

    المصدر: Nasdaq GlobeNewswire / 03 سبتمبر 2024 06:46:15   America/Chicago

    PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.

    • Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY, on Thursday, September 5, 2024, at 10:00 a.m. ET
    • Cantor Global Healthcare Conference 2024 in New York, NY on Tuesday, September 17, 2024, at 1:55 p.m. ET

    A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

    Additionally, management will attend the 2024 Wells Fargo Healthcare Conference on Friday, September 6, 2024.

    About Amicus Therapeutics
    Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

    CONTACT:

    Investors:
    Amicus Therapeutics
    Andrew Faughnan
    Vice President, Investor Relations
    afaughnan@amicusrx.com
    (609) 662-3809

    Media:
    Amicus Therapeutics
    Diana Moore
    Head of Global Corporate Affairs and Communications
    dmoore@amicusrx.com
    (609) 662-5079

    FOLD–G


    Primary Logo

شارك على،